Inflammatory Dermatosis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for inflammatory dermatosis. 22 active patents protecting 2 drugs from 2+ originators. First major cliff: 2032. Daily refresh.

2
Approved drugs
22
Active US patents
57/100
Avg vulnerability
—
Annual revenue covered

Originators in Inflammatory Dermatosis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Merck/Upjohn) 14 patents Fougera Pharms 8 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating inflammatory dermatosis. Each bar = one year. Y-axis scaled to peak year (4 patents).

1
28
4
30
4
32
4
33
4
34
1
35
2
36

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Cortef
hydrocortisone
 Generic (originally Merck/Upjohn) 14 64 — 2032-11-19
Temovate
CLOBETASOL PROPIONATE
 Fougera Pharms 8 50 — 2028-11-05

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12133914 Cortef method of use 75 2043-02-23
11904046 Cortef method of use 75 2043-02-23
11179465 Temovate method of use 64 2030-08-31
8460641 Temovate method of use 63 2028-11-05
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19
9675559 Cortef method of use 62 2033-01-10
9675559 Cortef method of use 62 2033-01-10

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9855334 Temovate formulation 25 2035-03-11
10588913 Temovate formulation 38 2036-05-09
10064875 Temovate method of use 51 2030-08-31
10588914 Temovate method of use 51 2030-08-31
9956231 Temovate method of use 51 2030-08-31
11376262 Temovate method of use 58 2036-05-09
9649280 Cortef method of use 62 2034-05-12
9649280 Cortef method of use 62 2034-05-12
9649280 Cortef method of use 62 2034-05-12
9649280 Cortef method of use 62 2034-05-12

Related